Royal Philips Electronics has released the BiPAP autoSV Advanced, its latest device for treating complicated sleep-disordered breathing patients.
The system is designed to effectively manage challenging sleep apnea cases.
__________
Posts tagged as:
BiPAP
Royal Philips Electronics today showcased the next generation Philips Respironics Sleep Therapy System at Medtrade 2009, a conference and expo for the home medical equipment industry.
The arrival of the new product line brings advances in sleep apnea therapy, the manufacturer says, that will benefit millions of sleep apnea sufferers, as well as bring new solutions to healthcare providers trying to meet today’s healthcare challenges.
__________
Royal Philips Electronics has appointed Eoghan O’Lionaird to lead Philips Home Healthcare Solutions’ Sleep business as Senior Vice President and General Manager, effective immediately.
“We are delighted to have Eoghan [pronounced “Owen”] take over the reins of our sleep business,” says Don Spence, Chief Executive Officer, Philips Home Healthcare Solutions.
__________
Moderate to severe obstructive sleep apnea is associated with an increased risk of death from any cause in middle-aged adults, especially men, according to new results from a landmark study supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health.
__________
The Centers for Medicare & Medicaid Services (CMS) revises the reimbursement rates for all services. During the review and revision process for the coming year, there’s often at least one or two areas that bring about heated discussion in the private sector over reimbursement, generally because of a reduction or a less-than-wanted/less-than-desired increase. This year, as over the past few years, home oxygen was a hot topic.
CMS announced late last year it was reviewing issues related to sleep apnea. The reason given was because the number of Medicare claims over the past few years have shot up like rocket. Much of that is attributed to patient education, community awareness, and various outreach efforts, such as those initiated by Awake In America and other organizations.
__________
People with even minimally symptomatic obstructive sleep apnea (OSA) may be at increased risk for cardiovascular disease because of impaired endothelial function and increased arterial stiffness, according to a study in the November 2008 issue of American Journal of Respiratory and Critical Care Medicine.
Their findings suggested that minimally symptomatic OSA is a cardiovascular risk factor to a degree not previously known.
__________
A study published in the Journal of Clinical Sleep Medicine suggests screening patients with Type 2 diabetes for obstructive sleep apnea (OSA) and treating those who have obstructive sleep apnea with xPAP therapy could improve the management of their hyperglycemia and might favorably influence their long-term prognosis.
According to Arthur Dawson, M.D., Scripps Clinic Sleep Center, it is not surprising that many diabetics have sleep apnea since Type 2 diabetes and obstructive sleep apnea are both conditions that are becoming much more common because of the obesity epidemic.
__________
A small, portable device used for the home diagnosis of obstructive sleep apnea has been deemed very reliable, according to research findings presented at the 2008 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in Chicago, IL.
According to the study, Reliability of Holter Oximetry for Home Sleep Apnea Testing, authored by researchers with the New York Otolaryngology group, 120 patients over a four-month period used Holter oximeters for home sleep testing, registering a 97 percent data recovery rate during that period. Furthermore, patients reported an average comfort score of 2 (on a scale of 1 to 10, where 1 is the most comfortable).
__________